Loading stock data…
InMode Ltd. designs (INMD)
$14.74+0.11 (+0.75%)
After Hours$14.74-0.00 (-0.01%)· Last close Jun 29
InMode Ltd.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
InMode Ltd. in the Healthcare sector is trading at $14.74 with a market capitalization of $817M. Wall Street consensus targets $14.33 (3 analysts), implying a -2.8% move over the next 12 months. The stock is currently 12% below its 52-week high of $16.74, remaining 2.6% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $82.02M↓ | $103.85M↑ | $93.17M↓ | $95.60M↑ | $77.87M |
| Gross Profit | $61.55M↓ | $81.30M↑ | $72.31M↓ | $76.45M↑ | $60.91M |
| Operating Income | $10.06M↓ | $25.99M↑ | $20.90M↓ | $22.88M↑ | $15.62M |
| Net Income | $11.56M↓ | $27.02M↑ | $21.86M↓ | $26.74M↑ | $18.20M |
Peer Comparison
JNJUNHPFE
Fundamentals
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe,...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$816.97M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
13.19%
Volume
Today's trading volume
555,900
Recent News
Medical Aesthetics Play Flies On Unsolicited Takeover Bid; Why It Makes Sense
Medical aesthetics outlet InMode received an unsolicited takeover bid from MN Business Strategy on Wednesday, sending the stock flying.
Sector Update: Healthcare Stocks Advance Late Afternoon
Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index adding 0.8% a
INMD Stock Heads For Best Day In Nearly Six Months – How Does The Latest Takeover Proposal Compare To Steel Partners’ Offer?
InMode disclosed an unsolicited takeover proposal worth $16.2 per share, a 21% premium to its last close.
Inmode Ltd (INMD) Reports Solid Numbers in a Soft Market
Inmode Ltd (NASDAQ:INMD) is one of the best micro and small cap stocks to buy according to Jim Simons’ Renaissance Technologies. Inmode Ltd (NASDAQ:INMD) reported its Q1 2026 results on May 6, saying revenue rose 5% YoY to $82 million. The Israeli medical device company delivered topline growth even as it operated in a soft […]
Doma Perpetual Buys Another $5.6 Million of Nomad Foods With the Stock Down 20% in 2026
Nomad Foods is a leading European frozen foods producer with a broad portfolio of well-known brands sold across major supermarket chains.